Pfizer Inc. (PFE) News
Follow Pfizer Inc. (PFE) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 157 public stories across 62 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.
M
Pfizer Q3'26 Earnings Preview: EPS Estimate at 0.73 USD
Pfizer is scheduled to report Q3'26 results on November 03 before the market opens. Revenue is estimated at 15.85 billion USD, with EPS at 0.73 USD.
EQUITY | Nov 02, 2026, 12:00 PM UTC
M
EU Patent Court Invalidates Enanta Patent in Pfizer Dispute
The EU Unified Patent Court invalidated an Enanta patent in its dispute with Pfizer over Paxlovid.
REGULATION | Oct 29, 2026, 08:24 PM UTC
M
UPC Invalidates Enanta Patent in Paxlovid Dispute
The Unified Patent Court declared Enanta’s patent invalid in a dispute involving Paxlovid.
REGULATION | Oct 29, 2026, 08:24 PM UTC
M
Lilly Shares Hit Record High After Raising Forecasts
Lilly shares reached record highs after the company raised forecasts tied to its obesity medicines.
EARNINGS | Oct 29, 2026, 02:34 PM UTC
M
US session market picture: S&P 500 +0.13%, Nasdaq 100 +0.12%; EUR/USD +0.01%, WTI +2.45%, WBD leads volume
US session market picture. US index futures: S and P futures is up 0.13 percent, Nasdaq futures is up 0.12 percent, Dow futures is up 0.13 percent and Russell futures is up 0.04 percent. In currencies, the dollar index i
EQUITY | Oct 28, 2026, 02:30 PM UTC
M
Pfizer Q3'26 Earnings Preview: Revenue Estimate 15.86B USD
Pfizer is scheduled to report Q3'26 results on November 03 before the market opens. Revenue is estimated at 15.86 billion USD and EPS at 0.73 USD.
EQUITY | Oct 27, 2026, 11:00 AM UTC
M
Pfizer’s Elrexfio improves progression-free survival in Phase 3 myeloma study
EQUITY | Oct 27, 2026, 10:46 AM UTC
M
Pfizer Says ELREXFIO Phase 3 Trial Met Primary PFS Endpoint
Pfizer said MagnetisMM-32 met its primary endpoint, with ELREXFIO monotherapy reducing the risk of progression or death versus three standard regimens in RRMM. PFS was 68% at 18 months; median PFS was not yet reached. Ov
EQUITY | Oct 27, 2026, 10:45 AM UTC
M
Pfizer’s Elrexfio Meets Primary Endpoint in Phase 3 Study
Pfizer said Elrexfio met the primary endpoint in the Phase 3 MagnetisMM-32 study for RRMM.
EQUITY | Oct 27, 2026, 10:45 AM UTC
M
Pfizer Says ELREXFIO Meets Primary Endpoint in Phase 3 Study
Pfizer announced topline results from the Phase 3 MagnetisMM-32 study of ELREXFIO in adults with relapsed or refractory multiple myeloma.
EQUITY | Oct 27, 2026, 10:45 AM UTC
M
FDA Approves Pfizer’s TALZENNA and XTANDI for Earlier-Stage Metastatic Prostate Cancer
The FDA approved Pfizer’s TALZENNA plus XTANDI for earlier-stage metastatic prostate cancer.
REGULATION | Oct 26, 2026, 06:36 PM UTC
M
FDA Expands Approval of Pfizer’s TALZENNA- XTANDI Combination
The FDA approved the TALZENNA and XTANDI combination for men with metastatic androgen pathway modulation-naïve or -sensitive prostate cancer.
REGULATION | Oct 26, 2026, 05:44 PM UTC
M
Pfizer Phase 3 TALAPRO-3 Data Show 52% Lower Risk of Progression or Death
EQUITY | Oct 26, 2026, 05:41 PM UTC
M
FDA Approves Talazoparib With Enzalutamide for Prostate Cancer
The US FDA approved the combination for metastatic HRR-mutated prostate cancer.
REGULATION | Oct 26, 2026, 04:43 PM UTC
M
Treasury Proposes Bans on U.S. Investment in Chinese Biotech, AI
The U.S. Treasury Department proposed restrictions on American investment in Chinese biotech, artificial intelligence and advanced memory chips. The proposal could cut off a source of new drugs for the pharmaceutical ind
REGULATION | Oct 23, 2026, 08:09 AM UTC
M
US session market picture: S&P 500 +0.39%, Nasdaq 100 +0.11%; EUR/USD +0.18%, WTI -0.61%, WBD leads volume
US session market picture. US index futures: S and P futures is up 0.39 percent, Nasdaq futures is up 0.11 percent, Dow futures is up 1.04 percent and Russell futures is up 1.7 percent. In currencies, the dollar index is
EQUITY | Oct 20, 2026, 06:00 PM UTC
M
US session market picture: S&P 500 +0.29%, Nasdaq 100 +0.04%; EUR/USD +0.18%, WTI -0.44%, WBD leads volume
US session market picture. US index futures: S and P futures is up 0.29 percent, Nasdaq futures is up 0.04 percent, Dow futures is up 0.93 percent and Russell futures is up 1.56 percent. In currencies, the dollar index i
EQUITY | Oct 20, 2026, 05:30 PM UTC
M
Wall Street Rises as Healthcare Stocks Rally and Oil Retreats
U.S. main indexes moved higher Tuesday, supported by a surge in healthcare stocks and softer oil prices, extending a recovery from last week's technology-led selloff. Brent crude slipped 1.1% after touching a five-month
EQUITY | Oct 20, 2026, 04:38 PM UTC
M
US session market picture: S&P 500 +0.25%, Nasdaq 100 -0.03%; EUR/USD +0.14%, WTI -0.56%, WBD leads volume
US session market picture. US index futures: S and P futures is up 0.25 percent, Nasdaq futures is down 0.03 percent, Dow futures is up 0.88 percent and Russell futures is up 1.34 percent. In currencies, the dollar index
EQUITY | Oct 20, 2026, 04:30 PM UTC
M
US session market picture: S&P 500 +0.31%, Nasdaq 100 +0.05%; EUR/USD +0.16%, WTI -0.99%, WBD leads volume
US session market picture. US index futures: S and P futures is up 0.31 percent, Nasdaq futures is up 0.05 percent, Dow futures is up 0.94 percent and Russell futures is up 1.67 percent. In currencies, the dollar index i
EQUITY | Oct 20, 2026, 04:00 PM UTC
M
US session market picture: S&P 500 +0.43%, Nasdaq 100 +0.26%; EUR/USD +0.18%, WTI -1.59%, WBD leads volume
US session market picture. US index futures: S and P futures is up 0.43 percent, Nasdaq futures is up 0.26 percent, Dow futures is up 1.02 percent and Russell futures is up 1.66 percent. In currencies, the dollar index i
EQUITY | Oct 20, 2026, 03:30 PM UTC
M
US session market picture: S&P 500 +0.41%, Nasdaq 100 +0.18%; EUR/USD +0.38%, WTI -1.08%, WBD leads volume
US session market picture. US index futures: S and P futures is up 0.41 percent, Nasdaq futures is up 0.18 percent, Dow futures is up 0.86 percent and Russell futures is up 1.16 percent. In currencies, the dollar index i
EQUITY | Oct 20, 2026, 02:30 PM UTC
M
US session market picture: S&P 500 -0.28%, Nasdaq 100 -1%; EUR/USD +0.19%, WTI +0.31%, WBD leads volume
US session market picture. US index futures: S and P futures is down 0.28 percent, Nasdaq futures is down 1 percent, Dow futures is up 0.64 percent and Russell futures is up 0.67 percent. In currencies, the dollar index
EQUITY | Oct 20, 2026, 02:00 PM UTC
L
Pfizer Shares Hit 52-Week High as Drugmakers Rally
Pfizer shares reached $29.88 Thursday, clearing the previous 52-week peak of $29.21, as drugmakers rose broadly. The FDA approved a Tukysa regimen on Oct. 7.
EQUITY | Oct 15, 2026, 04:00 PM UTC
M
Energyx Signs Binding 10-Year Lithium Offtake With Trafigura
Pantera Minerals says Energyx has signed a binding 10-year lithium offtake agreement with Trafigura.
COMMODITIES | Oct 15, 2026, 01:24 AM UTC
M
US session market picture: S&P 500 -0.42%, Nasdaq 100 -0.76%; EUR/USD -0.74%, WTI +1.42%, WBD leads volume
US session market picture. US index futures: S and P futures is down 0.42 percent, Nasdaq futures is down 0.76 percent, Dow futures is up 0.15 percent and Russell futures is down 1.11 percent. In currencies, the dollar i
EQUITY | Oct 14, 2026, 02:03 PM UTC
H
Stephen King Slams Trump’s New Press Secretary as Past Vaccine Conspiracy Theories, Third-Term Posts Spark Fresh Controversy: 'She Appears to Have Tried to…'
Author Stephen King has criticized President Donald Trump’s new White House press secretary, Katie Zacharia, over her past social media posts promoting vaccine-related claims, questioning the 2020 election results and al
LIVE | Oct 12, 2026, 09:12 AM UTC
H
A New War on Cancer? NIH's Vaccine Initiative Sparks Biotech Stock Rally
A nationwide initiative to accelerate personalized cancer vaccine development is drawing fresh investor interest in vaccine makers, sending several biotechnology and pharmaceutical stocks higher Friday. Moderna, Inc. (NA
LIVE | Oct 09, 2026, 07:11 PM UTC
M
Pfizer reports positive Phase 3 results for vitiligo drug LITFULO
Pfizer announced that its once-daily drug LITFULO (ritlecitinib) demonstrated significant improvements in facial and total body repigmentation compared to a placebo in two Phase 3 trials for nonsegmental vitiligo. The co
EQUITY | Oct 02, 2026, 03:15 PM UTC
M
US session market picture: S&P 500 +0.23%, Nasdaq 100 +0.41%; EUR/USD -0.4%, WTI +0.46%, WBD leads volume
US session market picture. US index futures: S and P futures is up 0.23 percent, Nasdaq futures is up 0.41 percent, Dow futures is up 0.14 percent and Russell futures is down 0.12 percent. In currencies, the dollar index
EQUITY | Oct 01, 2026, 01:30 PM UTC
M
Pfizer Acquires Metsera
Pfizer has acquired Metsera, a biotechnology company.
EQUITY | Oct 01, 2026, 07:01 AM UTC
M
US session market picture: S&P 500 -0.14%, Nasdaq 100 +0.32%; EUR/USD -0.12%, WTI +1.28%, WBD leads volume
US session market picture. US index futures: S and P futures is down 0.14 percent, Nasdaq futures is up 0.32 percent, Dow futures is down 0.76 percent and Russell futures is down 0.38 percent. In currencies, the dollar i
EQUITY | Sep 30, 2026, 08:30 PM UTC
M
US session market picture: S&P 500 +0.14%, Nasdaq 100 +0.71%; EUR/USD -0.17%, WTI +1.22%, WBD leads volume
US session market picture. US index futures: S and P futures is up 0.14 percent, Nasdaq futures is up 0.71 percent, Dow futures is down 0.63 percent and Russell futures is down 0.11 percent. In currencies, the dollar ind
EQUITY | Sep 30, 2026, 08:01 PM UTC
M
US session market picture: S&P 500 +0.26%, Nasdaq 100 +0.72%; EUR/USD -0.11%, WTI +1.36%, WBD leads volume
US session market picture. US index futures: S and P futures is up 0.26 percent, Nasdaq futures is up 0.72 percent, Dow futures is down 0.45 percent and Russell futures is down 0.01 percent. In currencies, the dollar ind
EQUITY | Sep 30, 2026, 07:30 PM UTC
M
US session market picture: S&P 500 +0.26%, Nasdaq 100 +0.64%; EUR/USD -0.09%, WTI +1.43%, NVDA leads volume
US session market picture. US index futures: S and P futures is up 0.26 percent, Nasdaq futures is up 0.64 percent, Dow futures is down 0.46 percent and Russell futures is down 0.1 percent. In currencies, the dollar inde
EQUITY | Sep 30, 2026, 07:00 PM UTC
M
US session market picture: S&P 500 +0.33%, Nasdaq 100 +0.72%; EUR/USD -0.09%, WTI +1.47%, NVDA leads volume
US session market picture. US index futures: S and P futures is up 0.33 percent, Nasdaq futures is up 0.72 percent, Dow futures is down 0.35 percent and Russell futures is unchanged at 0 percent. In currencies, the dolla
EQUITY | Sep 30, 2026, 06:31 PM UTC
M
US session market picture: S&P 500 +0.37%, Nasdaq 100 +0.67%; EUR/USD -0.07%, WTI +1.68%, NVDA leads volume
US session market picture. US index futures: S and P futures is up 0.37 percent, Nasdaq futures is up 0.67 percent, Dow futures is down 0.2 percent and Russell futures is up 0.01 percent. In currencies, the dollar index
EQUITY | Sep 30, 2026, 06:00 PM UTC
M
US session market picture: S&P 500 +0.35%, Nasdaq 100 +0.65%; EUR/USD -0.04%, WTI +1.71%, NVDA leads volume
US session market picture. US index futures: S and P futures is up 0.35 percent, Nasdaq futures is up 0.65 percent, Dow futures is down 0.29 percent and Russell futures is down 0.02 percent. In currencies, the dollar ind
EQUITY | Sep 30, 2026, 05:30 PM UTC
M
US session market picture: S&P 500 +0.48%, Nasdaq 100 +0.78%; EUR/USD -0.04%, WTI +2.19%, NVDA leads volume
US session market picture. US index futures: S and P futures is up 0.48 percent, Nasdaq futures is up 0.78 percent, Dow futures is down 0.16 percent and Russell futures is up 0.08 percent. In currencies, the dollar index
EQUITY | Sep 30, 2026, 05:00 PM UTC
M
US session market picture: S&P 500 +0.48%, Nasdaq 100 +0.78%; EUR/USD -0.07%, WTI +2.27%, NVDA leads volume
US session market picture. US index futures: S and P futures is up 0.48 percent, Nasdaq futures is up 0.78 percent, Dow futures is down 0.13 percent and Russell futures is up 0.05 percent. In currencies, the dollar index
EQUITY | Sep 30, 2026, 04:30 PM UTC
M
US session market picture: S&P 500 +0.46%, Nasdaq 100 +0.71%; EUR/USD +0.01%, WTI +2.57%, NVDA leads volume
US session market picture. US index futures: S and P futures is up 0.46 percent, Nasdaq futures is up 0.71 percent, Dow futures is down 0.14 percent and Russell futures is up 0.05 percent. In currencies, the dollar index
EQUITY | Sep 30, 2026, 04:00 PM UTC
M
US session market picture: S&P 500 +0.55%, Nasdaq 100 +0.76%; EUR/USD +0.09%, WTI +2.63%, NVDA leads volume
US session market picture. US index futures: S and P futures is up 0.55 percent, Nasdaq futures is up 0.76 percent, Dow futures is up 0.09 percent and Russell futures is up 0.46 percent. In currencies, the dollar index i
EQUITY | Sep 30, 2026, 03:30 PM UTC
M
US session market picture: S&P 500 +0.52%, Nasdaq 100 +0.73%; EUR/USD +0.11%, WTI +2.23%, EA leads volume
US session market picture. US index futures: S and P futures is up 0.52 percent, Nasdaq futures is up 0.73 percent, Dow futures is up 0.01 percent and Russell futures is up 0.24 percent. In currencies, the dollar index i
EQUITY | Sep 30, 2026, 03:01 PM UTC
M
US session market picture: S&P 500 +0.58%, Nasdaq 100 +0.79%; EUR/USD +0.11%, WTI +2.03%, EA leads volume
US session market picture. US index futures: S and P futures is up 0.58 percent, Nasdaq futures is up 0.79 percent, Dow futures is up 0.15 percent and Russell futures is up 0.35 percent. In currencies, the dollar index i
EQUITY | Sep 30, 2026, 02:32 PM UTC
L
Major drugmakers turn to China for licensing deals
Novo Nordisk OMXCOP:NOVO_B said on Tuesday it will pay up to $2.6 billion to Jiangsu Hengrui Pharmaceuticals SSE:600276 for the rights to an experimental weight-loss pill, making it the latest drugmaker to license China-
GEOPOLITICS | Sep 30, 2026, 12:18 PM UTC
L
Pharma sector doubles down on AI to slash costs, timelines
Pharmaceutical companies are increasingly turning to artificial intelligence to accelerate research and development, betting on new modeling tools and automated labs to improve efficiency across their pipelines.Industry
NEWS | Sep 29, 2026, 01:35 PM UTC
L
Pfizer, Moderna lose bids to escape Bayer US mRNA patent lawsuit
By Blake BrittainA federal judge in Delaware on Monday rejected Pfizer NYSE:PFE, BioNTech NASDAQ:BNTX and Moderna's NASDAQ:MRNA requests to dismiss patent lawsuits filed against them by Bayer's XETR:BAYN Monsanto unit ov
REGULATION | Sep 28, 2026, 06:20 PM UTC
L
US drugmakers turn to China for licensing deals
Merck NYSE:MRK on Monday agreed to pay Chinese biotech SciBrunch Therapeutics $400 million upfront for global rights to an experimental cancer drug, making it the latest US drugmaker to license China-developed medicines.
GEOPOLITICS | Sep 28, 2026, 02:31 PM UTC
L
BioNTech to shutter sites in Germany, Singapore as no buyers emerge
German COVID—19 vaccine maker BioNTech NASDAQ:BNTX said on Monday it would close sites in Germany and Singapore because it failed to find buyers after pivoting away from pandemic-era manufacturing."Despite the best effor
NEWS | Sep 28, 2026, 01:04 PM UTC
H
Full Transcript: Pfizer Q2 2026 Earnings Call
Pfizer (NYSE: PFE ) released second-quarter financial results and hosted an earnings call on Tuesday. Read the complete transcript below. APIs provide real-time access to earnings call transcripts and financial data. Vis
LIVE | Sep 28, 2026, 11:10 AM UTC
L
Weekly Recap: New and acquired product sales surge and COVID revenue decline
Pfizer Inc. (NYSE:PFE) said new product sales surged while COVID revenue will decline through 2026, unveiled clinical progress on tivunatamig and obesity candidate PF-3944, pursued big China deals and pricing/AI shifts,
GEOPOLITICS | Sep 28, 2026, 11:06 AM UTC
H
Pfizer Advances Today’s Cancer Care and Tomorrow's Potential Breakthroughs at ESMO
Pfizer Inc. (NYSE:PFE) will present data from 45 company-sponsored, investigator-sponsored, and collaborative research abstracts at the European Society for Medical Oncology (ESMO) Congress, taking place October 23-27, 2
GEOPOLITICS | Sep 28, 2026, 10:45 AM UTC
H
Innovation Is Driving A New Bull Market In Biotech. 16 Picks. — Barron's
Biotechnology stocks are soaring this year as medical advances and merger activity rekindle investor interest. More gains lie ahead, our healthcare panel says.By Lauren R. RublinA tidal wave of innovation in biotechnolog
MNA | Sep 26, 2026, 01:37 AM UTC
H
Innovation Is Driving a New Bull Market in Biotech. 16 Ways to Play It, From Our Roundtable Experts. — Barrons.com
Biotechnology stocks are soaring this year as medical advances and merger activity rekindle investor interest. More gains lie ahead, our healthcare panel says.By Lauren R. RublinA tidal wave of innovation in biotechnolog
MNA | Sep 25, 2026, 03:40 PM UTC
L
PFE - Pfizer Invites Public to View and Listen to Webcast of November 3 Conference Call with Analysts
PFE - Pfizer Invites Public to View and Listen to Webcast of November 3 Conference Call with Analysts
NEWS | Sep 22, 2026, 02:09 PM UTC
L
Pfizer CEO Bourla to attend Trump-Xi state dinner
Pfizer CEO Albert Bourla plans to attend U.S. President Donald Trump’s state dinner for Chinese President Xi Jinping on Thursday evening, a source familiar with the matter said.
GEOPOLITICS | Sep 22, 2026, 01:57 PM UTC
M
Trump to announce all states in Medicaid drug pricing model
President Donald Trump is set to announce Friday the participation of all states in a Medicaid drug pricing model, building on deals with 17 major pharmaceutical companies struck over the past year.
REGULATION | Sep 18, 2026, 05:22 PM UTC
M
US considers rules preserving most pharma licensing deals with China
Sources say the US is working on rules for pharmaceutical investment in China that would likely preserve companies’ ability to strike most licensing deals for Chinese drugs.
REGULATION | Sep 18, 2026, 10:00 AM UTC
H
Trump administration to extend Medicaid most-favored-nation drug pricing nationwide
Semafor reports the administration will announce Friday that all 50 states will have most-favored-nation pricing for certain drugs in Medicaid programs.
REGULATION | Sep 18, 2026, 09:47 AM UTC
M
US session market picture: S&P 500 +0.3%, Nasdaq 100 +0.5%; EUR/USD -0.03%, WTI -2.02%, KVUE leads volume
US session market picture. US index futures: S and P futures is up 0.3 percent, Nasdaq futures is up 0.5 percent, Dow futures is up 0.11 percent and Russell futures is up 0.17 percent. In currencies, the dollar index is
EQUITY | Sep 16, 2026, 01:30 PM UTC